Knowledge is Power: Three Important Things to Know about Recent Clinical Trials on Extended Aromatase Inhibitor Therapy

Last month at the San Antonio Breast Cancer Symposium (SABCS) the results of three extended anti-estrogen therapy trials were presented that could have a big impact on the standard of care for ER+ breast cancer patients and survivors. You may have heard buzz about the trial results, and what they mean for the ER+ breast … Continue reading Knowledge is Power: Three Important Things to Know about Recent Clinical Trials on Extended Aromatase Inhibitor Therapy

VIEW MORE